King of Prussia, PA, United States of America

Sharada Manns

This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignee: Glaxosmithkline Intellectual Property (No.2) Limited. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sharada Manns. Retrieved from https://idiyas.com/inventor/sharada-manns

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Sharada Manns

Introduction

Sharada Manns is an accomplished inventor based in King of Prussia, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on hydroxy formamide derivatives.

Latest Patents

Sharada Manns holds 1 patent for his invention titled "Hydroxy formamide derivatives and their use." This patent discloses compounds that have the formula wherein R1, R2, and R3 are defined, along with methods of making and using these compounds. Notably, these compounds serve as inhibitors of BMP1, TLL1, and/or TLL2, and are relevant in the treatment of diseases associated with the activity of these proteins.

Career Highlights

Sharada is currently associated with GlaxoSmithKline Intellectual Property (No. 2) Limited, where he continues to advance his research and development efforts. His work has been instrumental in exploring new therapeutic avenues in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Sarah E Dowdell and Hilary Schenck Eidam, who contribute to the collaborative environment that fosters innovation and research excellence.

Conclusion

Sharada Manns exemplifies the spirit of innovation in the pharmaceutical field, with his patent on hydroxy formamide derivatives showcasing his commitment to advancing medical science. His contributions are paving the way for new treatments and therapies that can significantly impact patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…